University of Washington Medicine Diabetes Institute at South Lake Union
Welcome,         Profile    Billing    Logout  
 1 Trial 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Khakpour, Dori
GLIDING, NCT04623086: Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose

Completed
4
59
US
Insulin Degludec, Tresiba, Insulin Glargine, Lantus, Placebo
University of Washington
Type 1 Diabetes
09/22
12/23
RT1D, NCT05822609: Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Recruiting
2
60
Canada, US
Semaglutide, Placebo
University of Washington, Juvenile Diabetes Research Foundation, University of Colorado, Denver, Providence Healthcare, University of Toronto
Diabetic Kidney Disease, Type 1 Diabetes
06/26
06/26
NCT06273124: Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

Completed
N/A
260
US
SteadiSet Extended Wear Infusion Set
Tandem Diabetes Care, Inc., Jaeb Center for Health Research
Type1diabetes
12/24
12/24
NCT05799781: Two Way Crossover Closed Loop MPC vs Control IQ

Recruiting
N/A
30
US
MPC closed-loop system, t:slim X2 pump with Dexcom G6 CGM and Control IQ
Oregon Health and Science University, University of Washington
Type 1 Diabetes
04/25
04/25
RADIANT, NCT05544266: Rare and Atypical Diabetes Network

Recruiting
N/A
2000
US
University of South Florida, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Diabetes Mellitus Progression, Glucose Intolerance, Glucose Metabolism Disorders, Metabolic Disease, Endocrine; Complications, Endocrine System Diseases
09/30
09/30
Thirumalai, Arthi
GLIDING, NCT04623086: Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose

Completed
4
59
US
Insulin Degludec, Tresiba, Insulin Glargine, Lantus, Placebo
University of Washington
Type 1 Diabetes
09/22
12/23
Chao, Jing
GLIDING, NCT04623086: Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose

Completed
4
59
US
Insulin Degludec, Tresiba, Insulin Glargine, Lantus, Placebo
University of Washington
Type 1 Diabetes
09/22
12/23
TIGHT, NCT05135676: Time in Glucose Hospital Target

Completed
N/A
169
US
Blinded CGM, Commercially available Dexcom CGM, real-time CGM
Jaeb Center for Health Research, DexCom, Inc.
Diabetes Mellitus, Type 2
03/24
03/24

Download Options